As a means of providing immediate pain relief for cancer patients, scientists have begun conducting clinical research on delivering medical cannabis concentrates through an inhaler.
This new method of delivery will increase accessibility for cancer patients who are treated with long-term pharmaceutical cannabis (such as sublingual tablets), and those suffering from acute cancer pain who prefer to avoid smoking cannabis.
“Every piece of clinical research that helps manage treatment using medical cannabis is important. Delivering treatment via inhalation is characterized by a quicker response time than oral or sublingual tablets,” said Dr. Itay Gur-Aryeh, Director of the Pain Unit at Sheba Hospital, Tel Hashomer,
The inhaler includes an attached vaporizer to which the patient adds the measured dose of cannabis extract for inhalation. The cannabis extract includes a precise dose of active ingredients.